According to Peck et al. (2021), viscosupplementation demonstrates the ability to reduce pain and enhance joint functional mobility. This comprehensive review highlights hyaluronic acid injections as an effective non-surgical solution…
According to Sullivan et al. (2022), the study on physicians’ use of and preferences for FDA-approved Prescribing Information (PI) revealed a preference for clarity and specificity in drug labeling. This…
According to the Arthritis Foundation, shoulder osteoarthritis (OA), while less common than knee or hip OA, affects nearly one in three people over 60. This prevalence underscores the reality that…
According to Malemud (2015), osteoarthritis (OA) triggers innate and adaptive immune responses, leading to inflammation. This inflammation is marked by increased proinflammatory substances contributing significantly to the disease’s progression. Significantly,…
According to Testa et al. (2021), more than 10% of knee osteoarthritis (OA) patients receive intra-articular injections of different drugs, such as hyaluronic acid and platelet-rich plasma. This statistic emphasizes…